Hims & Hers Health, Inc. (HIMS)

Market Cap	5.65B -38.5%
Revenue (ttm)	2.35B +59.0%
Net Income	128.37M +1.8%
EPS	0.51 -3.7%
Shares Out	227.94M
PE Ratio	48.35
Forward PE	46.77
Dividend	n/a
Ex-Dividend Date	n/a

Volume	42,981,707
Open	24.07
Previous Close	23.84
Day's Range	23.25 - 24.82
52-Week Range	13.74 - 70.43
Beta	2.61
Analysts	Hold
Price Target	28.21 (+13.89%)
Earnings Date	Feb 23, 2026

About HIMS

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and de...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Employees: 2,442
• Stock Exchange: NYSE
• Ticker Symbol: HIMS
• Website: https://www.hims.com

Financial Performance

In 2025, Hims & Hers Health's revenue was $2.35 billion, an increase of 59.00% compared to the previous year's $1.48 billion. Earnings were $128.37 million, an increase of 1.85%.

Analyst Summary

According to 14 analysts, the average rating for HIMS stock is "Hold." The 12-month stock price target is $28.21, which is an increase of 13.89% from the latest price.

Price Target

$28.21

(13.89% upside)

Analyst Consensus: Hold